Author

A. V. Ljubimov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

K. L. Black· 2 shared A. A. Kramerov· 1 shared A. Chiechi· 1 shared A. Galstyan· 1 shared A. J. Korman· 1 shared A. Rentsendorj· 1 shared D. C. Lee· 1 shared D. Hawes· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

K. L. Black

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of retinal tau oligomers, citrullinated tau, and other tau isoforms in early and advanced AD and relations to disease status

H. Shi, N. Mirzaei, Y. Koronyo, M. R. Davis, E. Robinson, G. M. Braun, O. Jallow, A. Rentsendorj, V. K. Ramanujan, J. Fert-Bober, A. A. Kramerov, A. V. Ljubimov, L. S. Schneider, W. G. Tourtellotte, D. Hawes, , M. Koronyo-Hamaoui

This study quantifies retinal tau isoforms in early and advanced AD and links them to brain pathology and cognitive status.

bioRxiv · Feb 13, 2024 · PreprintPathology

Nano immunoconjugates crossing blood-brain barrier activate local brain tumor immune system for glioma treatment

A. Galstyan, A. Chiechi, A. J. Korman, T. Sun, L. L. Isreal, O. Braubach, R. Patil, E. Shatalova, V. A. Ljubimov, J. Markman, Z. Grodzinski, K. L. Black, M. L. Penichet, E. Holler, A. V. Ljubimov, , J. Y. Ljubimova

This study develops nano immunoconjugates that cross the blood-brain barrier to activate local immune responses against gliomas, improving survival in treated mice.

bioRxiv · Nov 9, 2018 · PreprintImmunology